AU2003282543B2 - Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents - Google Patents

Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents Download PDF

Info

Publication number
AU2003282543B2
AU2003282543B2 AU2003282543A AU2003282543A AU2003282543B2 AU 2003282543 B2 AU2003282543 B2 AU 2003282543B2 AU 2003282543 A AU2003282543 A AU 2003282543A AU 2003282543 A AU2003282543 A AU 2003282543A AU 2003282543 B2 AU2003282543 B2 AU 2003282543B2
Authority
AU
Australia
Prior art keywords
compound
formula
cancer
feraly
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003282543A
Other languages
English (en)
Other versions
AU2003282543A1 (en
Inventor
Mahmoud A. Elsohly
Ahmed M. Galal
Samir A. Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Mississippi
Original Assignee
University of Mississippi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Mississippi filed Critical University of Mississippi
Publication of AU2003282543A1 publication Critical patent/AU2003282543A1/en
Application granted granted Critical
Publication of AU2003282543B2 publication Critical patent/AU2003282543B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003282543A 2002-10-15 2003-10-09 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents Ceased AU2003282543B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/271,960 US6790863B2 (en) 2002-10-15 2002-10-15 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents
US10/271,960 2002-10-15
PCT/US2003/032049 WO2004034976A2 (en) 2002-10-15 2003-10-09 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer nd anti-infective agents

Publications (2)

Publication Number Publication Date
AU2003282543A1 AU2003282543A1 (en) 2004-05-04
AU2003282543B2 true AU2003282543B2 (en) 2009-02-26

Family

ID=32069214

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003282543A Ceased AU2003282543B2 (en) 2002-10-15 2003-10-09 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents

Country Status (7)

Country Link
US (3) US6790863B2 (enExample)
EP (1) EP1551389A4 (enExample)
JP (1) JP2006504753A (enExample)
AU (1) AU2003282543B2 (enExample)
CA (1) CA2501942A1 (enExample)
MX (1) MXPA05003920A (enExample)
WO (1) WO2004034976A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790863B2 (en) * 2002-10-15 2004-09-14 University Of Mississippi Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents
CA2570961C (en) * 2004-06-21 2015-09-01 University Of Mississippi Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities
CN1311832C (zh) * 2005-01-12 2007-04-25 四川科伦药业股份有限公司 溴代二氢青蒿素的医药用途
FR2899586B1 (fr) * 2006-04-11 2008-06-20 Sanofi Aventis Sa Dimeres de derives d'artemisinine, leur preparation et leur application en therapeutique
US7566465B2 (en) * 2006-12-21 2009-07-28 The United States Of America As Represented By The Secretary Of The Army Artemisinins in the clinical and veterinary management of kinetoplastid infections
FR2934593B1 (fr) * 2008-07-29 2010-09-10 Pf Medicament Derives dimeriques d'artemisinine et application en therapie anticancereuse
GB2489641B (en) 2010-01-22 2018-02-21 Council Scient Ind Res A new series of artemisinin derivatives and process for preparation thereof
US9006467B2 (en) 2011-02-14 2015-04-14 Councel of Scientific & Industrial Research 1,2,3-triazole containing artemisinin compounds and process for preparation thereof
US9675582B2 (en) 2011-10-25 2017-06-13 U.S. Phytotherapy, Inc. Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
EP2770985A4 (en) 2011-10-25 2015-01-21 U S Phytotherapy Inc ARTEMISININE AND BERBERINE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
US9358261B2 (en) 2011-10-25 2016-06-07 U.S. Phytotherapy, Inc. Additional artemisinin and berberine compositions and methods of making
US9487538B2 (en) 2013-01-22 2016-11-08 The Johns Hopkins University Two-carbon linked artemisinin-derived trioxane dimers
WO2015041723A1 (en) 2013-09-17 2015-03-26 Kryptonite Group, Ltd Artemisinin-based combination therapy for treating viral mediated disease
CN106928274B (zh) * 2017-02-28 2019-09-10 东南大学 一种双氢青蒿素二倍体衍生物、其药物组合物及应用
CN109467565B (zh) * 2018-08-16 2020-07-10 云白药征武科技(上海)有限公司 双氢青蒿素三聚体及其制备方法和应用
JP7534726B2 (ja) * 2019-02-26 2024-08-15 マフムード エイ エルソーリー リーシュマニア症の処置用に選択されたアーテミシニンダイマー
CN110305017B (zh) * 2019-08-09 2022-02-25 大理大学 降桉烷倍半萜类化合物及其药物组合物和制备方法与应用
CN110448551A (zh) * 2019-08-23 2019-11-15 西南大学 二氢青蒿素衍生物在制备抗血管生成药物中的应用
CN110354270B (zh) * 2019-08-30 2022-04-15 中国中医科学院中药研究所 一种青蒿琥酯聚乙二醇衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647674A (en) * 1985-10-07 1987-03-03 Pennwalt Corporation Bis-(dibenzo[b,d]pyranyloxy) propanes
US4952603A (en) 1988-06-20 1990-08-28 Elferaly Farouk S Method for the isolation of artemisinin from Artemisia annua
IT1247476B (it) * 1991-06-14 1994-12-17 Fidia Spa Derivati della cumarina.
US5677468A (en) * 1995-06-29 1997-10-14 Hauser, Inc. Artemisinin dimer compounds having anticancer activity
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
US6790863B2 (en) * 2002-10-15 2004-09-14 University Of Mississippi Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents

Also Published As

Publication number Publication date
EP1551389A4 (en) 2008-08-27
MXPA05003920A (es) 2005-06-17
JP2006504753A (ja) 2006-02-09
US20040229938A1 (en) 2004-11-18
AU2003282543A1 (en) 2004-05-04
CA2501942A1 (en) 2004-04-29
WO2004034976A2 (en) 2004-04-29
US20040072896A1 (en) 2004-04-15
WO2004034976A3 (en) 2004-08-12
US7098242B2 (en) 2006-08-29
US6790863B2 (en) 2004-09-14
US20040266860A1 (en) 2004-12-30
EP1551389A2 (en) 2005-07-13

Similar Documents

Publication Publication Date Title
US6790863B2 (en) Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer and anti-infective agents
Guo et al. Biologically active quassinoids and their chemistry: potential leads for drug design
Galal et al. Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity
AU739687B2 (en) C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities
US6586464B2 (en) Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same
WO2011017998A1 (zh) 藤黄酸环合类似物及其制备方法和应用
US6156790A (en) C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
CA2570961C (en) Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities
WO2012111025A2 (en) 1,2,3-triazole containing artemisinin compounds and process for preparation thereof
El-Feraly et al. A new method for the preparation of arteether and its C-9 epimer
ElSohly et al. New orally active artemisinin dimer antimalarials
Ying Artemisinin derivatives and analogues
CA2787722C (en) A series of artemisinin derivatives and process for preparation thereof
CN105250260A (zh) 一种1,3-茚满二酮螺环化合物的抗肿瘤用途
JP2009274956A (ja) ニーム種子由来の悪性腫瘍治療薬
JPH06287191A (ja) マイカラマイド様物質
Anesini Design, Synthesis, and Application of a Rapidly Diversifiable Trioxacarcin Pharmacophore in Antibody-Drug Conjugates

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired